These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32073257)

  • 1. Repurposing of Drugs Is a Viable Approach to Develop Therapeutic Strategies against Central Nervous System Related Pathogenic Amoebae.
    Anwar A; Khan NA; Siddiqui R
    ACS Chem Neurosci; 2020 Aug; 11(16):2378-2384. PubMed ID: 32073257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of repurposing drug candidates for the treatment of diseases caused by pathogenic free-living amoebae.
    Rice CA; Colon BL; Chen E; Hull MV; Kyle DE
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008353. PubMed ID: 32970675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three encephalitis-causing amoebae and their distinct interactions with the host.
    Sarink MJ; van der Meijs NL; Denzer K; Koenderman L; Tielens AGM; van Hellemond JJ
    Trends Parasitol; 2022 Mar; 38(3):230-245. PubMed ID: 34758928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-eating Amoebae Infection: Challenges and Opportunities in Chemotherapy.
    Mungroo MR; Anwar A; Khan NA; Siddiqui R
    Mini Rev Med Chem; 2019; 19(12):980-987. PubMed ID: 30868950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Balamuthia mandrillaris and anti-Naegleria fowleri effects of drugs conjugated with various nanostructures.
    Siddiqui R; Boghossian A; Alqassim SS; Kawish M; Gul J; Jabri T; Shah MR; Khan NA
    Arch Microbiol; 2023 Apr; 205(5):170. PubMed ID: 37017767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea.
    Visvesvara GS; Moura H; Schuster FL
    FEMS Immunol Med Microbiol; 2007 Jun; 50(1):1-26. PubMed ID: 17428307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Proposals for Amendments in the Diagnosis and Treatment of Encephalitis caused by Free-living Amoebae".
    Baig AM
    Infect Disord Drug Targets; 2020; 20(2):115-121. PubMed ID: 30961516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of amoebic encephalitis: Are the amoebae being credited to an 'inside job' done by the host immune response?
    Baig AM
    Acta Trop; 2015 Aug; 148():72-6. PubMed ID: 25930186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic free-living amoebae: epidemiology and clinical review.
    Trabelsi H; Dendana F; Sellami A; Sellami H; Cheikhrouhou F; Neji S; Makni F; Ayadi A
    Pathol Biol (Paris); 2012 Dec; 60(6):399-405. PubMed ID: 22520593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiamoebic Properties of Laboratory and Clinically Used Drugs against Naegleria fowleri and Balamuthia mandrillaris.
    Siddiqui R; Mungroo MR; Anuar TS; Alharbi AM; Alfahemi H; Elmoselhi AB; Khan NA
    Antibiotics (Basel); 2022 May; 11(6):. PubMed ID: 35740156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infections Caused by Free-Living Amoebae.
    Kofman A; Guarner J
    J Clin Microbiol; 2022 Jan; 60(1):e0022821. PubMed ID: 34133896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Glucokinases from Pathogenic Free-Living Amoebae.
    Milanes JE; Suryadi J; Monaghan NP; Harding EM; Morris CS; Rozema SD; Khalifa MM; Golden JE; Phan IQ; Zigweid R; Abendroth J; Rice CA; McCord HT; Wilson S; Fenwick MK; Morris JC
    Antimicrob Agents Chemother; 2022 Jun; 66(6):e0237321. PubMed ID: 35604214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting CNS Related Protist Pathogens: Calcium Ion Dependency in the Brain-Eating Amoebae.
    Baig AM; Khaleeq A; Nazim F
    ACS Chem Neurosci; 2020 Aug; 11(16):2385-2387. PubMed ID: 31840980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing in vitro approaches for screening anti-parasitic drugs against the brain-eating amoeba Naegleria fowleri.
    Martín-Escolano R; Yiangou L; Kazana E; Robinson GK; Michaelis M; Tsaousis AD
    Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():204-212. PubMed ID: 34875573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opportunistic amoebae: challenges in prophylaxis and treatment.
    Schuster FL; Visvesvara GS
    Drug Resist Updat; 2004 Feb; 7(1):41-51. PubMed ID: 15072770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repositioning of Guanabenz in Conjugation with Gold and Silver Nanoparticles against Pathogenic Amoebae
    Anwar A; Mungroo MR; Anwar A; Sullivan WJ; Khan NA; Siddiqui R
    ACS Infect Dis; 2019 Dec; 5(12):2039-2046. PubMed ID: 31612700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innovative Methodology in the Discovery of Novel Drug Targets in the Free-Living Amoebae.
    Baig AM
    Curr Drug Targets; 2019; 20(1):60-69. PubMed ID: 29697029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opportunistic free-living amoebal pathogens.
    Mungroo MR; Khan NA; Maciver S; Siddiqui R
    Pathog Glob Health; 2022 Mar; 116(2):70-84. PubMed ID: 34602025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic nanoparticle-conjugated bisindoles and hydrazinyl arylthiazole as novel antiamoebic agents against brain-eating amoebae.
    Kanwal ; Mungroo MR; Anwar A; Ali F; Khan S; Abdullah MA; Siddiqui R; Khan KM; Khan NA
    Exp Parasitol; 2020 Nov; 218():107979. PubMed ID: 32866583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aryl Quinazolinone Derivatives as Novel Therapeutic Agents against Brain-Eating Amoebae.
    Mungroo MR; Shahbaz MS; Anwar A; Saad SM; Khan KM; Khan NA; Siddiqui R
    ACS Chem Neurosci; 2020 Aug; 11(16):2438-2449. PubMed ID: 31961126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.